发明名称 Oligomer-calcium channel blocker conjugates
摘要 The invention provides small molecule drugs that are chemically modified by covalent attachment of a water soluble oligomer. A conjugate of the invention, when administered by any of a number of administration routes, exhibits characteristics that are different from the characteristics of the small molecule drug not attached to the water soluble oligomer.
申请公布号 US8748648(B2) 申请公布日期 2014.06.10
申请号 US20080674139 申请日期 2008.09.03
申请人 Nektar Therapeutics 发明人 Ren Zhongxu;Deng Bo-Liang;Riggs-Sauthier Jennifer;Harvey Micah
分类号 C07C255/00 主分类号 C07C255/00
代理机构 代理人
主权项 1. A compound comprising a calcium channel blocker residue covalently attached via a stable linkage to a water-soluble, non-peptidic oligomer, wherein the calcium channel blocker residue is a residue of a calcium channel blocker having the formula:wherein: R1 is a member selected from the group consisting of lower alkyl, cyclohexyl, and phenyl; each R is independently selected from the group consisting of hydrogen, chlorine, lower alkoxy and lower alkyl, wherein at least one R is selected from chlorine, lower alkoxy and lower alkyl; and (n) is an integer from 2 to 3, inclusive; andwherein the water soluble, non-peptidic oligomer is made of 2 to 30 monomers.
地址 San Francisco CA US